Last update 01 Nov 2024
United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.

United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.

Private Company|
2009|
Beijing Shi, China

Overview

Tags

Other Diseases
Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
D1 receptor(Dopamine D1 receptor)1

Related

1
Drugs associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
Methylergonovine Maleate
Target
D1 receptor
Mechanism
D1 receptor antagonists
Active Org.
Weifang Zhongshi Pharmaceutical Co. Ltd.Weifang Zhongshi Pharmaceutical Co. Ltd. [+7]
Originator Org.
EDISON THERAPEUTICS LLC
Active Indication
Hemorrhage [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date19 Nov 1946
1
Clinical Trials associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
CTR20160647 / RecruitingPhase 1
马来酸甲麦角新碱片在健康人体内采用随机、开放、单中心药代动力学研究
[Translation] A randomized, open-label, single-center pharmacokinetic study of methylergonovine maleate tablets in healthy volunteers
100 Clinical Results associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Deals associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with United Yisheng (Beijing) Pharmaceutical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Methylergonovine Maleate
 ( D1 receptor )		Uterine Hemorrhage
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free